These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Growth and autoantibodies to IA-2 in children with type 1 diabetes. Cianfarani S; Bonfanti R; Manca Bitti ML; Chiumello G; Boscherini B Lancet; 2000 Oct; 356(9240):1521. PubMed ID: 11081554 [No Abstract] [Full Text] [Related]
23. Autoantibodies to IA-2 not detected in NOD mice or BB rats. DeSilva MG; Jun HS; Yoon JW; Notkins AL; Lan MS Diabetologia; 1996 Oct; 39(10):1237-8. PubMed ID: 8897014 [No Abstract] [Full Text] [Related]
24. Expression of protein tyrosine phosphatase-like molecule ICA512/IA-2 induces growth arrest in yeast cells and transfected mammalian cell lines. Papakonstantinou T; Myers MA; Jois J; Roucou X; Prescott M; Rowley MJ; Mackay IR J Autoimmun; 2001 Aug; 17(1):51-61. PubMed ID: 11488637 [TBL] [Abstract][Full Text] [Related]
25. Definition of multiple ICA512/phogrin autoantibody epitopes and detection of intramolecular epitope spreading in relatives of patients with type 1 diabetes. Kawasaki E; Yu L; Rewers MJ; Hutton JC; Eisenbarth GS Diabetes; 1998 May; 47(5):733-42. PubMed ID: 9588444 [TBL] [Abstract][Full Text] [Related]
26. Evaluation of the efficacy of the combination of multiple autoantibodies to islet-specific antigens in Korean type 1 diabetic patients. Park Y; Lee H; Takino H; Abiru N; Kawasaki E; Eisenbarth GS Acta Diabetol; 2001; 38(1):51-6. PubMed ID: 11487177 [TBL] [Abstract][Full Text] [Related]
27. Sensitive non-isotopic assays for autoantibodies to IA-2 and to a combination of both IA-2 and GAD65. Chen S; Willis J; Maclean C; Ananieva-Jordanova R; Amoroso MA; Brooking H; Powell M; Collins A; Bennett S; Mitchell S; Burne P; Furmaniak J; Smith BR Clin Chim Acta; 2005 Jul; 357(1):74-83. PubMed ID: 15963796 [TBL] [Abstract][Full Text] [Related]
28. Comments on the relation among GAD-65, IA-2 antibodies and body adiposity. Porte D; Seeley RJ; Woods SC; Baskin DG; Figlewicz DP; Schwartz MW Diabetologia; 2000 Jan; 43(1):134. PubMed ID: 10672457 [No Abstract] [Full Text] [Related]
29. Isolation and characterisation of a human monoclonal autoantibody to the islet cell autoantigen IA-2. Ananieva-Jordanova R; Evans M; Nakamatsu T; Premawardhana LD; Sanders J; Powell M; Chen S; McGrath V; Belton C; Arnold C; Baker S; Betterle C; Zanchetta R; Smith BR; Furmaniak J J Autoimmun; 2005 Jun; 24(4):337-45. PubMed ID: 15869863 [TBL] [Abstract][Full Text] [Related]
30. A simple and rapid microSepharose assay for GAD65 and ICA512 autoantibodies in diabetes. Diabetes Incidence Study in Sweden (DISS). Schranz DB; Bekris L; Landin-Olsson M; Törn C; Niläng A; Toll A; Grönlund H; Toivola B; Lernmark A J Immunol Methods; 1998 Apr; 213(1):87-97. PubMed ID: 9671127 [TBL] [Abstract][Full Text] [Related]
31. Increased in vivo frequency of IA-2 peptide-reactive IFNgamma+/IL-4- T cells in type 1 diabetic subjects. Herzog BA; Ott PA; Dittrich MT; Quast S; Karulin AY; Kalbacher H; Karges W; Tary-Lehmann M; Lehmann PV; Boehm BO; Durinovic-Belló I J Autoimmun; 2004 Aug; 23(1):45-54. PubMed ID: 15236752 [TBL] [Abstract][Full Text] [Related]
32. Identification of the 37-kDa antigen in IDDM as a tyrosine phosphatase-like protein (phogrin) related to IA-2. Hawkes CJ; Wasmeier C; Christie MR; Hutton JC Diabetes; 1996 Sep; 45(9):1187-92. PubMed ID: 8772720 [TBL] [Abstract][Full Text] [Related]
34. How does antibody combination really predict IDDM in the general population? Fortune telling--not fortune spending. Pinhas-Hamiel O; Sprecher E; Vardi P Diabetes Metab Rev; 1998 Sep; 14(3):252-4. PubMed ID: 9816473 [No Abstract] [Full Text] [Related]
35. Human monoclonal antibodies isolated from type I diabetes patients define multiple epitopes in the protein tyrosine phosphatase-like IA-2 antigen. Kolm-Litty V; Berlo S; Bonifacio E; Bearzatto M; Engel AM; Christie M; Ziegler AG; Wild T; Endl J J Immunol; 2000 Oct; 165(8):4676-84. PubMed ID: 11035111 [TBL] [Abstract][Full Text] [Related]
36. Detection of autoreactive T cells in type 1 diabetes using coded autoantigens and an immunoglobulin-free cytokine ELISPOT assay: report from the fourth immunology of diabetes society T cell workshop. Nagata M; Kotani R; Moriyama H; Yokono K; Roep BO; Peakman M Ann N Y Acad Sci; 2004 Dec; 1037():10-5. PubMed ID: 15699487 [TBL] [Abstract][Full Text] [Related]
37. IA-2 is not required for the development of diabetes in NOD mice. Kubosaki A; Miura J; Notkins AL Diabetologia; 2004 Jan; 47(1):149-50. PubMed ID: 14614561 [No Abstract] [Full Text] [Related]